Literature DB >> 22706750

Mesenteric panniculitis patients requiring emergency surgery: report of three cases.

Mustafa Duman1, Osman Koçak, Olgaç Fazli, Cengiz Koçak, Ali Emre Atici, Uğur Duman.   

Abstract

Mesenteric panniculitis is a rare, benign disease characterized by a chronic non-specific inflammatory process of mesenteric fat tissue with unknown etiology. The small bowel mesentery is affected mostly. This process rarely involves the large intestine mesentery. Mesenteric panniculitis includes symptoms as abdominal pain, nausea and vomiting, diarrhea, constipation, and fever. In our cases, we had difficulty in the preoperative diagnosis as the clinical changes imitated an obstruction or ischemia of the small bowel. All the cases required emergency abdominal surgery and partial jejunal resection. The aim of this article was to present three cases of mesenteric panniculitis of the small bowel mesentery requiring emergency surgery together with a short review of the literature.

Entities:  

Mesh:

Year:  2012        PMID: 22706750     DOI: 10.4318/tjg.2012.0284

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  3 in total

Review 1.  Intra-abdominal fat. Part II: Non-cancerous lesions of the adipose tissue localized beyond organs.

Authors:  Andrzej Smereczyński; Katarzyna Kołaczyk; Elżbieta Bernatowicz
Journal:  J Ultrason       Date:  2016-03-29

2.  Mesenteric panniculitis in a child misdiagnosed as appendicular mass: a case report and review of literature.

Authors:  Nisreen Rumman; George Rumman; Barakat Sharabati; Rami Zagha; Nimer Disi
Journal:  Springerplus       Date:  2014-02-06

3.  Sclerosing mesenteritis mimicking metachronous peritoneal metastases from descending colon adenocarcinoma.

Authors:  Toshifumi Watanabe; Shiro Terai; Tomoya Tsukada; Masaki Takeshita; Koshi Matsui; Koji Amaya; Masahide Kaji; Kiichi Maeda; Koichi Shimizu; Junko Saito; Kentaro Mochizuki; Akio Uchiyama
Journal:  World J Surg Oncol       Date:  2017-08-01       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.